Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma
about
Gaps in nutritional research among older adults with cancerPrognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.Prognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients.Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladderSarcopenia as a prognostic factor in hepatolithiasis-associated intrahepatic cholangiocarcinoma patients following hepatectomy: a retrospective study.Prognostic significance of sarcopenia in upper tract urothelial carcinoma patients treated with radical nephroureterectomy.Prevalence of Sarcopenia and Associated Outcomes in the Clinical Setting.Impact of sarcopenia in the management of urological cancer patients.The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature.Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution study.Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population.Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy.An analysis of the types of recently published research in the field of cachexia.Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy.Clinical utility of bioelectrical impedance analysis in patients with locoregional muscle invasive or metastatic urothelial carcinoma: a subanalysis of changes in body composition during neoadjuvant systemic chemotherapy.Prognostic significance of cachexia score assessed by CT in male patients with small cell lung cancer.Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy.Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis.The preoperative sarcopenia status is associated with lymphovascular invasion in upper tract urothelial carcinoma patients treated with radical nephroureterectomy.Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases.Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer.Impact of postoperative changes in sarcopenic factors on outcomes after hepatectomy for hepatocellular carcinoma.Evaluation of sarcopenia in small-cell lung cancer patients by routine chest CT.Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy.Preoperative Computed Tomography-Determined Sarcopenia and Postoperative Outcome after Surgery for Non-Small Cell Lung Cancer.Diagnostic Criteria and Clinical Outcomes in Sarcopenia Research: A Literature Review.Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer
P2860
Q28067552-258FBB2A-935C-403B-8C09-E252C07DF95FQ36153929-5E6A1DF4-DD4D-4563-9A10-AF0AB2B30A50Q36255549-1C4C6803-3A58-4B2D-90F3-2EFE72C358F1Q36328773-D9C3A79E-4960-41F8-AF3F-41040BF15CC1Q36411789-1A9B1486-96B7-4FF4-B1FC-B1D420606978Q37321124-3779676A-FF68-4858-BE81-707921FFD79AQ38679380-3813A308-7681-48FB-8235-8FCC6F555116Q38749004-D9ADF2A7-BBAA-4001-B852-F61A653A6CCDQ38842194-B05E619B-A017-4A0E-9282-196A836FE5A5Q40648872-9E346176-F17A-4FCB-A1D0-216590FDD38AQ46429494-237F0352-E713-4DDE-A18A-56725742C4E2Q47356300-AE19FC51-1079-43DA-94D5-911DDD4A6E06Q47568983-6544F2FA-13E4-42DD-8D60-FAB323B66F48Q47801764-E6B9F014-D951-4CD8-A3EF-FE0C117A0005Q48206419-E5E6B551-A2EC-4BE2-8963-BE90199D3F3BQ48253920-1706DDD1-7EF9-43D1-900B-03C216081BBEQ48370859-05AED24C-9729-4F7F-839A-B30398CD49A8Q49479448-9EA88D67-BDA2-4B26-A919-A5C8C2F6D20AQ49540562-23BE4E73-8CCB-45A0-982C-3BB89DBF3969Q49943276-D1319A87-C936-433B-8D78-D89A72C5AA22Q50109104-AE7FFB89-1AED-40F2-BA60-02BB6A393E22Q50239119-B1D3099A-63CD-4A1B-800B-4712CBB04F81Q50881582-4A16DA01-1EA2-42D0-B903-0EBE9DC25A4DQ51434666-85EA46B6-F6B5-47FE-8F8D-EF6FF63C5299Q52738058-67A6DA4D-2251-4769-A2D6-4C8C2E2423D6Q54979042-8A710F0E-AC7B-499E-957F-5BADE077FD98Q58765612-BAE0C56B-969B-4824-B04D-79294A0F1D93
P2860
Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma
@ast
Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma
@en
type
label
Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma
@ast
Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma
@en
prefLabel
Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma
@ast
Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma
@en
P2093
P2860
P1433
P1476
Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma
@en
P2093
Fumitaka Koga
Ken-ichi Tobisu
Minato Yokoyama
Yasukazu Nakanishi
P2860
P304
P356
10.1371/JOURNAL.PONE.0115895
P407
P577
2015-01-22T00:00:00Z